Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renate Arnold

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
European Journal of Haematology|June 18, 2014
Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutationBenjamin N Ostendorf, Theis H Terwey, Philipp G Hemmati, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Anti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairmentAnne Flörcken, Antje van Lessen, Theis H Terwey, et al.
Mycoses|September 20, 2017
Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-time PCR methodSandra Elges, Renate Arnold, Oliver Liesenfeld, et al.
European Journal of Haematology|January 27, 2011
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplantsPhilipp G Hemmati, Theis H Terwey, Philipp le Coutre, et al.
Critical Care Research and Practice|May 20, 2016
Neutropenic Sepsis in the ICU: Outcome Predictors in a Two-Phase Model and Microbiology FindingsJan M Kruse, Thomas Jenning, Sibylle Rademacher, et al.
Haematologica|December 17, 2009
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemiaTheis H Terwey, Philipp G Hemmati, Peter Martus, et al.
European Journal of Haematology|October 22, 2013
Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remissionPhilipp G Hemmati, Anthea Schulze-Luckow, Theis H Terwey, et al.
Journal of Inherited Metabolic Disease|February 13, 2019
Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophyNils Waldhüter, Wolfgang Köhler, Philipp G Hemmati, et al.
International Journal of Hematology|February 25, 2010
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotypePhilipp G Hemmati, Theis H Terwey, Gero Massenkeil, et al.
Leukemia & Lymphoma|May 31, 2018
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survivalJana Ihlow, Sophia Gross, Annabel Sick, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
European Journal of Haematology|June 18, 2014
Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutationBenjamin N Ostendorf, Theis H Terwey, Philipp G Hemmati, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Anti-leukemia T cells in AML: TNF-α⁺ CD8⁺ T cells may escape detection and possibly reflect a stage of functional impairmentAnne Flörcken, Antje van Lessen, Theis H Terwey, et al.
Mycoses|September 20, 2017
Prospective evaluation of the SeptiFAST multiplex real-time PCR assay for surveillance and diagnosis of infections in haematological patients after allogeneic stem cell transplantation compared to routine microbiological assays and an in-house real-time PCR methodSandra Elges, Renate Arnold, Oliver Liesenfeld, et al.
European Journal of Haematology|January 27, 2011
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplantsPhilipp G Hemmati, Theis H Terwey, Philipp le Coutre, et al.
Critical Care Research and Practice|May 20, 2016
Neutropenic Sepsis in the ICU: Outcome Predictors in a Two-Phase Model and Microbiology FindingsJan M Kruse, Thomas Jenning, Sibylle Rademacher, et al.
Haematologica|December 17, 2009
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemiaTheis H Terwey, Philipp G Hemmati, Peter Martus, et al.
European Journal of Haematology|October 22, 2013
Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remissionPhilipp G Hemmati, Anthea Schulze-Luckow, Theis H Terwey, et al.
Journal of Inherited Metabolic Disease|February 13, 2019
Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for adult cerebral X-linked adrenoleukodystrophyNils Waldhüter, Wolfgang Köhler, Philipp G Hemmati, et al.
International Journal of Hematology|February 25, 2010
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotypePhilipp G Hemmati, Theis H Terwey, Gero Massenkeil, et al.
Leukemia & Lymphoma|May 31, 2018
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survivalJana Ihlow, Sophia Gross, Annabel Sick, et al.
Pageof 7